NE BUSINESS BUREAU
MUMBAI, AUG 25
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, on Monday announced that a manufacturing unit in its Ahmedabad campus has received approval from ANVISA, which is Brazil’s national health regulatory agency. This approval follows a successful inspection conducted by the agency in May 2025 and enables Eris to enter Brazil, the largest pharmaceutical market in South America.
A company spokesperson said that this approval by a stringent regulatory authority like ANVISA is a tangible endorsement of the GMP and quality systems at the Company’s manufacturing facilities. The said manufacturing facility has been successfully inspected by various other regulatory agencies earlier in the year.
